OGRD联盟通过在日本和新加坡的伙伴关系将其癌症研究平台扩大到亚洲和中东和北非。 The OGRD Alliance expands its cancer research platform to Asia and MENA via partnerships in Japan and Singapore.

总部设在迪拜的OGRD联盟在日本和新加坡建立了伙伴关系之后,将其PLPC-DB磷磷蛋白质质组平台和OncoVix方案扩展到亚洲、中东和北非地区。 The OGRD Alliance, based in Dubai, has expanded its PLPC-DB phospholipoproteomic platform and OncoVix Program into Asia and the Middle East and North Africa regions, following partnerships in Japan and Singapore. 该倡议由Ramón Gutiérrez Sandoval博士领导,包括四个综合组成部分,通过11次国际会议情况介绍、5份经同行审查的出版物、3份专利和2次民主力量联盟前审计得到验证。 The initiative, led by Dr. Ramón Gutiérrez Sandoval, includes four integrated components validated through 11 international conference presentations, five peer-reviewed publications, three patents, and two pre-FDA audits. OncoVix方案利用匿名患者数据来证明可复制的、真实世界的结果。 The OncoVix Program uses anonymized patient data to demonstrate reproducible, real-world outcomes. 在阿联酋法律和银行合作伙伴的支持下,迪拜现已成为区域金融、物流和监管合规枢纽。 Dubai now serves as a regional hub for finance, logistics, and regulatory compliance, supported by UAE legal and banking partners. 2025年愿景奖获得者Gutiérrez博士将在即将举行的生物技术和投资活动上发言,强调本区域在全球生命科学创新中日益重要的作用。 Dr. Gutiérrez, a 2025 Visionary Award recipient, will speak at upcoming biotech and investment events, highlighting the region’s growing role in global life sciences innovation.